IMCD acquires South Africa’s Ethnichem
…and expands partnership with DuPont Tate & Lyle Bio Products
Distributor IMCD Group has acquired Ethnichem, an important local player in South Africa’s personal care and pharmaceutical industries. According to IMCD, the deal will enable the company to consolidate its position in both sectors.
“Ethnichem’s strength in the personal care and pharmaceutical sectors perfectly complements IMCD,” said Mark Hepburn, managing director of IMCD South Africa. “Their product offering fits very well with the current IMCD South African product portfolio, broadening the growth possibilities in the market.”
Ethnichem’s owner and md Alan Rahme added: “This move will allows us access to better resources and to be able to supply our customers with all the benefits that come from being part of an internationally recognised company.”
Under the transaction, all Ethnichem staff will move over to IMCD, which will also assume control of Ethnichem’s laboratory facility, while current Ethnichem md Rahme will lead IMCD’s personal care business in South Africa.
IMCD is also expanding its partnership with DuPont Tate & Lyle Bio Products for the distribution of Zemea propanediol. The company will now be responsible for distributing the bio-based alternative to petroleum-derived glycols in Australia, New Zealand, Turkey, Poland and South Africa, in addition to previously managed regions: France, the UK, Ireland, Belgium, the Netherlands, Norway, Finland, Sweden, Denmark, Luxembourg, Russia, Estonia, Latvia and Lithuania.
